Smart applications of bionanosensors for BCR/ABL fusion gene detection in leukemia - ScienceDirect
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease | Leukemia
The Dawn of Allosteric BCR-ABL1 Drugs: From a Phenotypic Screening Hit to an Approved Drug | Journal of Medicinal Chemistry
The BCR-ABL1 Gene – All About Blood
Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia: Molecular Therapy - Nucleic Acids
BCR-ABL1 и ABL1 - QuantideX® qPCR BCR-ABL IS, Asuragen, USA.
Acute Myeloid Leukemia (AML) with BCR-ABL1 - Compendium of Cancer Genome Aberrations
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
The Clinical Significance of BCR-ABL1 Mutations in Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation - Transplantation and Cellular Therapy, Official Publication of the ...
BCR/ABL t(9;22) Translocation Assay for Gel Detection - Invivoscribe
Pharmaceutics | Free Full-Text | BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia